New facility in Sector 51 offers advanced, affordable, and patient-centric dialysis services for NCR patients
Indoco received the Establishment Inspection Report from the USFDA for its API manufacturing facility
The inspection concluded with zero form 483 observations
USFDA has determined that the inspection classification of this facility is "No Action Indicated" (NAI) with zero 483 observation
These accolades highlight our unwavering commitment to maintaining the highest safety standards
Aarogya program aims to improve the overall health outcomes for the community by offering comprehensive health screenings, diagnostic support, and increased health awareness
Dr. Sanjay Behari, Director of Sree Chitra Tirunal Institute for Medical Sciences and Technology, Thiruvananthapuram, as the President of the Medical Assessment and Rating Board
_256_384.jpg)
The regulator carried out a routine current Good Manufacturing Practices (cGMP) inspection from March 28 to April 4.
The first such initiative under the MoU will involve establishing a Centre of Excellence for Renal Sciences at the Tomo Riba Institute of Health & Medical Sciences (TRIHMS)
The initiative launched in 2019 has touched over 10,000 lives with 500+ screening camps and aims to double its reach in the next 2 years
Subscribe To Our Newsletter & Stay Updated
